UNH vs MRK
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | MRK |
|---|---|---|
| Price | $418.09 | $145.27 |
| Market cap | $375.28B | $358.41B |
| P/E ratio | 26.9 | 117.2 |
| ROE | 15.77% | 6.96% |
| Profit margin | 3.53% | 4.77% |
| Revenue growth | -0.40% | 5.10% |
| Dividend yield | 2.22% | 2.34% |
| Beta | 0.61 | 0.22 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs MRK in plain English
- UNH and MRK are similar in size.
- UNH is cheaper on earnings (P/E 26.9 vs 117.2).
- UNH earns a higher return on equity (16% vs 7%).
- MRK is growing revenue faster (5% vs -0%).
- MRK has the higher dividend yield (2.34% vs 2.22%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.